Botox, xeomin, dysport

Decisions, decisions! As if deciding whether to get help with fine lines and wrinkles wasn’t bad enough. You also have to make a decision on which product to go with. Botox, Xeomin, Dysport which one is best? Is there a difference?
Botox, Xeomin, and Dysport are all used to temporarily treat the frown lines between the eyebrows. So is there really something that makes them any different?
Botox is used to paralyze the muscles under the skin that cause those fine lines and wrinkles. Once injected botox prevents the muscles from releasing acetylcholine which is what causes the muscles to contract then causing those wrinkles. Botox lasts anywhere from three to six months.
Xeomin as botox and dysport is used to help smooth out those frown lines that tend to appear between the brows. It is used to block the nerve activity making a temporary minimization in muscle activity. Xeomin has no additives and the effect after being injected appear after a week. It is similar to botox  dysport when it comes to duration on results. It can last from 3 to 6 months.
If you are looking for more of a natural look Dysport would be a great option as mentioned on Dysport is to give you more of a smooth natural look rather than a frozen look. There are five different points to where one injection of Dysport is used. Once injected the injection will temporarily stop the muscles between the brows to contract.
So as we see all three products are used for the same purpose. They are all used to help minimize and smooth out the appearance of those fine lines and wrinkles. Still unsure? Dr. Mark A. Bishara at The Paragon Plastic Surgery and Med Spa can help. Dr. Mark A. Bishara treats a large amount of patients weekly. So if in doubt come see Dr. Bishara he would be more than happy to help you make the best decision.


Sign up for Skype Consult or Office Visit today!


Medicis Pharmaceutical Corp is proud to  announce that the FDA has approved the use of the Restylane hyaluronic acid dermal filler to incorporate lip augmentation. Restylane was formerly approved to treat moderate to severe facial wrinkles and folds, such as the lines from the nose to the nasolabial folds. The new label will now include an indication for submucosal implantation for lip augmentation in patients over the age of 21.
Chairman and CEO of Medicis Jonah Shacknai, is pleased with FDA’s decision to expand the Restylane label to include lip augmentation. Restylane is now the first and only hyaluronic acid dermal filler approved in the United States for lip augmentation. 180 patients were evaluated during the study for six months. Safety was measured by adverse events reported throughout the study and patient diaries kept for two weeks after lip augmentation treatment.
Furthermore, Medicis designed nine lip safety assessments which were preformed at various intervals throughout the six month case study, including 72 hours after each treatment and again at two weeks after each treatment.
Mark A Bishara, M.D., P.A. Medical Director
This Information is Brought to you courtesy of Dr. Mark Bishara and The Paragon Plastic Surgery and Med Spa in Mansfield and Southlake.
Please also visit our Facebook page at Paragon Plastic Surgery and Medspa

We serve clients from the Dallas Fort Worth Metroplex: